Search for:
Category

Regulatory

Category

Since late 2020 a reimbursement fast-track program for the most innovative oncology and rare disease treatments (defined as highly innovative medicinal technologies (HIMT)). For example, the first ever HIMT has become reimbursed for this new procedure in less than two years since its authorization. We also observe an increasing number of rare disease therapies being reimbursed in a standard procedure and the Minister of Health has recently reported progress in the implementation of the Plan for Rare Disease for 2021-2023.

Switzerland is substantially revising and modernizing its insurance supervision laws, i.e., the federal law on the supervision of insurance carriers (Versicherungsaufsichtsgesetz) and the respective ordinance (Versicherungsaufsichtsverordnung). The new law is expected to come into effect on 1 July 2023 or 1 January 2024. It will introduce a new, risk-based supervision regime that allows for more tailor-made supervision.

There are many examples of non-resident shareholders of South African companies failing to endorse their shares. This constitutes a breach of South Africa’s Exchange Control Regulations and may be subject to penalties and/or imprisonment. This endorsement should be carried out as soon as possible after the acquisition of shares, and if this was not done, it should be rectified straight away.

In two recent cases, the Egyptian Competition Authority (ECA) issued infringement decisions against two dominant companies. In the first case, the ECA established that a company operating in the yeast industry has abused its dominance in a number of ways, including restricting passive sales between distributors and also engaging in retail price maintenance. In another case, the ECA was against a food delivery online e-platform for abusing its dominance by engaging in Most Favored Nation clauses with the restaurants in violation of Article 8 of the Egyptian Competition Law No. 3 for 2005.

On 30 August 2022, the Indonesian competition authority (“KPPU”) issued Circular No. 9/KPPU/SE/VIII/2022, clarifying that it will accept apostilled foreign official documents.
Since Indonesia acceded to the Apostille Convention in 2021, The KPPU’s position on this has been unclear, particularly with regard to how powers of attorney issued abroad should be processed. With this Circular, it the authority has now confirmed that documents issued in a member state of the Apostille Convention will only need to be notarized and apostilled to be accepted by KPPU.

KPPU, Indonesia’s competition authority, is taking an increasingly aggressive stance, as seen in its latest decision on partnerships between a large corporation and small and micro enterprises. In that case, a maximum fine of IDR 10 billion (approx. USD 670,000) was imposed on a large corporation that was viewed by KPPU as controlling the SMEs it partners with. This recent development could indicate the start of a more rigorous approach to enforcement by KPPU against SME partnerships.

This article, written by Clara Hansen, Candidate Attorney, and Angelo Tzarevski in Antitrust & Competition Practice, Johannesburg provides details on the Draft Block Exemption Regulations (“Regulations”) for Small, Micro and SMMEsMedium-Sized Businesses (SMMEs), which were published on 31 August 2022 after consultation with the Competition Commission. The Regulations are intended to enable collaboration between SMMEs and promote the growth and participation of SMMEs in the South African economy.

The guide provides key legal information on the regulatory environment for digital health, potential legal issues, and other hot topics at the intersection of healthcare, data and technology.
To learn more about the latest trends and developments in digital healthcare in the Philippines, access the Philippine chapter of Chambers and Partners Digital Healthcare Global Guide 2022, exclusively authored by Quisumbing Torres.